Merit Medical Systems Inc
MMSIMerit Medical Systems Inc is a global developer and manufacturer of innovative medical devices used in minimally invasive procedures, primarily in cardiology, radiology, urology, and critical care. Founded in 1987, the company focuses on creating products that improve patient outcomes and healthcare provider efficiency, offering a diverse portfolio of disposables, accessories, and innovative technologies for various diagnostic and therapeutic applications.
Company News
Merit Medical Systems has signed an asset purchase agreement with PENTAX Medical to acquire the C2 CryoBalloon device for $22 million, expanding its endoscopy portfolio in the gastroenterology market with technology to treat Barrett's esophagus and other gastrointestinal disorders.
Merit Medicine has integrated Willis Towers Watson's HealthMAPS® manuals into its Merit Predict predictive analytics solution, enabling more precise group health risk assessment by combining actuarial expertise with advanced predictive modeling.
Merit Medical received CE Mark approval for Embosphere Microspheres to treat knee osteoarthritis through genicular artery embolisation, offering a minimally invasive pain management option with proven clinical success.
Merit Medical Systems reported strong Q2 2025 financial results, with revenue of $382.5 million (up 13.2%), beating analyst estimates. The company showed robust growth in cardiovascular and endoscopy device segments and raised its full-year guidance.
The global blood pressure monitor market is projected to grow from USD 2.40 billion in 2025 to USD 4.36 billion by 2035, driven by aging populations, home healthcare, and AI-powered wearables. The rising prevalence of hypertension and technological advancements are key factors driving the market growth.
